01530.HK
3SBio Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 13.54
−1.53%Forward multiples
Based on analyst estimates
- P/E forward
- 10.11x
- P/E 2026E
- 12.10x
- P/E 2027E
- 11.52x
- P/E 2028E
- 9.94x
- P/S forward
- 3.09x
Trailing multiples
Trailing twelve months
- P/E TTM
- 3.47x
- PEG TTM
- 0.06x
- Price / book
- 1.01x
- Price / sales
- 1.57x
- Price / cash flow
- 2.89x
Enterprise value
- Enterprise value
- HKD 17.6B
- EV / sales
- 0.84x
- EV / EBITDA
- 1.31x
- EV / EBIT
- 1.37x
- Market cap
- HKD 32.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026